Investment
Features
FeesSafety
Academy
More
Pluang+

Compare New York Times Co (NYT) vs UnitedHealth Group Inc (UNH) Price & Performance

New York Times CoTrade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

New York Times Co vs UnitedHealth Group Inc — how do they compare? New York Times Co trades at $66.6 (market cap $10.96B), while UnitedHealth Group Inc trades at $394.14 (market cap $359.79B). The key difference: UnitedHealth Group Inc is far larger — about 32.8× New York Times Co's market cap, and UnitedHealth Group Inc pays the higher dividend (2.32%). Which is the better fit depends on your goals.

NYTUNH
Market Cap
$10.96B$359.79B
Sector
MediaHealth
52-Week High
$85.86$436.35
52-Week Low
$54.66$259.02
Enterprise Value
$10.36B$401.65B
Dividend Yield
1.35%2.32%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

New York Times Co

The New York Times Company (NYT) trades at $67.96, up 1.01% today, with a neutral technical signal and mixed moving averages. Recent earnings have consistently beaten estimates, with Q2 2026 EPS of $0.69 exceeding the $0.663 forecast. Revenue growth is steady, rising from $2.3B in 2022 to $2.8B in 2025, with net profit margins improving to 12.17%. The company maintains strong cash flow from operations at $584.49M in 2025. Analyst consensus is a $76.00 price target, though the majority recommend Hold.

Outlook remains cautiously optimistic given earnings momentum and solid fundamentals, but risks include the ongoing OpenAI copyright lawsuit and competitive pressures in digital media. The stock offers potential upside to the consensus target, supported by institutional buying interest, though sentiment is tempered by regulatory and litigation uncertainties.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $393.06, down 1.03% on the day, with a bullish technical signal from moving averages and strong analyst support. The company reported revenue of $447.57B in 2025, with net income of $12.06B, and has beaten EPS estimates in recent quarters. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns via dividends and buybacks.

The outlook for UNH is positive, driven by aging demographics, Medicare growth, and operational efficiencies, though risks include regulatory scrutiny and margin pressures. With 82.7% of analysts rating it a buy and a consensus price target of $475.47, the stock presents a compelling opportunity for long-term investors seeking exposure to healthcare stability and dividend growth.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About New York Times Co

New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as nytimes and various smartphone applications. Circulation of The New York Times is the source of revenue for the company, followed by print and digital advertising and its paid digital-only subscription to The New York Times. The company has a daily print circulation of over 500,000 and 1,000,000 on Sundays. The source of growth for The New York Times is its digital subscription service, which has over 1,000,000 paid users.

Read more on NYT

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH